GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » COGS-to-Revenue

CTC Bio (XKRX:060590) COGS-to-Revenue : 0.62 (As of Jun. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CTC Bio COGS-to-Revenue?

CTC Bio's Cost of Goods Sold for the three months ended in Jun. 2024 was ₩21,669 Mil. Its Revenue for the three months ended in Jun. 2024 was ₩34,817 Mil.

CTC Bio's COGS to Revenue for the three months ended in Jun. 2024 was 0.62.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. CTC Bio's Gross Margin % for the three months ended in Jun. 2024 was 37.76%.


CTC Bio COGS-to-Revenue Historical Data

The historical data trend for CTC Bio's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTC Bio COGS-to-Revenue Chart

CTC Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.80 0.76 0.67 0.69

CTC Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.69 0.70 0.63 0.62

CTC Bio COGS-to-Revenue Calculation

CTC Bio's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=94811.558 / 137878.037
=0.69

CTC Bio's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=21668.73 / 34817.4
=0.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTC Bio  (XKRX:060590) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

CTC Bio's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 21668.73 / 34817.4
=37.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


CTC Bio COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of CTC Bio's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CTC Bio Business Description

Traded in Other Exchanges
N/A
Address
94, Saengmyeonggwahakgwan-gil, Gangwon-do, Hongcheon, KOR, 25142
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

CTC Bio Headlines

No Headlines